Lexicon Pharmaceuticals LXRX Increase (Decrease) in Inventories
Increase (Decrease) in Inventories at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's increase (decrease) in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's increase (decrease) in inventories?
- Lexicon Pharmaceuticals (LXRX) reported increase (decrease) in inventories of -$5K in Q1 2026.
- How has Lexicon Pharmaceuticals's increase (decrease) in inventories changed year-over-year?
- Lexicon Pharmaceuticals's increase (decrease) in inventories increased by 83.3% year-over-year, from -$30K to -$5K.
- What does increase (decrease) in inventories mean?
- This represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. Fluctuations in this balance reflect changes in production levels, supply chain management, and anticipated future sales demand. Monitoring this helps investors gauge inventory turnover and potential obsolescence risks.